Spike Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 7.32 M
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 3.08%
- Profit Growth 1.93%
- Ebitda 2.05%
- Net Worth 22.22%
- Total Assets 20.63%
About Spike Pharmaceuticals
Spike Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 July 2008 and has a history of 16 years and six months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.32 M, as per Ministry of Corporate Affairs (MCA) records.
Kanakesathevar Balakrishnan, Vedavalli, Ramaswamy Palanivelu, and Two other members serve as directors at the Company.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232TN2008PTC068584
-
Company No.
068584
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Jul 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Spike Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vedavalli
|
Managing Director | 15-Jul-2008 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Kanakesathevar Balakrishnan
|
Director | 15-Jul-2008 | Current |
|
Ramaswamy Palanivelu
|
Director | 10-Nov-2008 | Current |
|
Gangadurai Meenakshi
|
Director | 12-Feb-2016 | Current |
|
Selvaraju Nevithitha
|
Director | 12-Feb-2016 | Current |
Financial Performance of Spike Pharmaceuticals.
Spike Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 3.08% increase. The company also saw a slight improvement in profitability, with a 1.93% increase in profit. The company's net worth Soared by an impressive increase of 22.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spike Pharmaceuticals?
In 2019, Spike Pharmaceuticals had a promoter holding of 41.56% and a public holding of 58.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Viewsure Developers LlpKanakesathevar Balakrishnan is a mutual person
-
Vedhaa Balaa Farm Llp
Kanakesathevar Balakrishnan, Vedavalli and 2 more are mutual person
-
-
Pattukkottai Colour Doppler Scan Private Limited
Kanakesathevar Balakrishnan and Vedavalli are mutual person
-
Pattukkotai Ct Scans Private Limited
Kanakesathevar Balakrishnan and Ramaswamy Palanivelu are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Spike Pharmaceuticals?
Unlock and access historical data on people associated with Spike Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spike Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spike Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.